(PharmaNewsWire.Com, February 23, 2017 ) According to the report Asia Pacific Liquid Biopsy market, published by Market Data Forecast, Asia-Pacific market is expected to increase at a CAGR of 31.23% in the forecast period of 2016-2021 and reach a value of USD 482.37 million by 2021 from USD 123.94 million in 2016.
The Asia-Pacific liquid biopsy market is projected to grow highest during the forecast period, primarily due to the increasing focus of players on this region. India and China are the Emerging countries in the Asia-Pacific region and expected to grow fast because of increased market access of each countrys population to healthcare resources. Asia-Pacific region is geographically segmented into China, India, Japan, Australia and South Korea. Liquid biopsy is a technique which satisfies patients with the best treatment and also doctors by providing potential screening for disease. Molecular characterization of the tumour can also be done by liquid biopsy and it provides ease of repeat sampling for monitoring genetic changes as the procedure is non-invasive.
Medical communities are extending support for the market which is acting as a key driver. Liquid biopsy technique is under advancement and is continuously improving, which is helping drive its adoption in clinical applications. There are lot of new technologies coming up in the market such as for cell capturing, sample preparation and DNA amplification are making significant progress. Rise in technological competition is acting as a restraint for the market.
The liquid biopsy market is mainly segmented by types of cancer into Lung Cancer, Pancreatic Cancer, Leukemia and Other Visceral Cancers. By Diagnostic approach they can be classified as Circulating Tumour cells (CTC), Circulating Tumour DNA (ctDNA), RNA in exosomes and Extra-Cellular Vesicles. Based on end users, the market is segmented into reference laboratories, hospital/physician laboratories, academic and research centers, and other end users. The market is bifurcate into blood, urine, plasma, saliva and Cerebrospinal fluid based upon sample type. CTCs (Circulating Tumour cells), the first such entities on the liquid biopsy scene, have accounted for a large share in the market. Cancer institute is the largest end user segment in terms of revenues and is expected to create substantial opportunity in global liquid biopsy market over the forecast period.
The Liquid Biopsy Market study offers the following deliverables:
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development.
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
Checkout related reports in the Diagnostic Category:
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
